Optimizing Machining and Production Performance March 4, 2022 Nikel Precision Group also implemented solutions that optimize tool performance to improve quality, as well as production intelligence that provides real-time insights into factory performance.
Is Manufacturing Ready for XR Technologies? March 3, 2022 XR technologies, comprising virtual reality, augmented reality and mixed reality processes and equipment, are making fundamental shifts in manufacturing.
Hexagon’s Make It Smarter America Tour Hits the Road August 11, 2021 Hexagon experts embark on a summer mission to make manufacturing smarter for users across the U.S.
How to Include More People of Color in Management July 21, 2021 Five experts outline ways companies can help existing racially diverse employees interested in management posts, actions those workers can take, ways recruiters can do better, and ways to prepare for the future.
With NIIMBL’s help, biopharmaceutical firms adjust to going to market ‘first together’ July 26, 2021 A shared testbed for innovation at NIIMBL represents, but doesn’t mimic, what’s happening in an individual firm’s lab.
Smart manufacturing not just for the big players anymore July 26, 2021 In a high-mix/low-volume environment, it’s not good enough to simply be part of the pack. Today you need to be out front and pulling away, powered by the best smart tech available.
Executive Discusses AI's Impact on Workers October 14, 2020 The CEO of an artificial intelligence company discusses how AI affects workers and how AI can be deployed well.
Neurala Announces Strategic Partnership with IMA Group October 20, 2020 Vision AI software company Neurala announced a new strategic partnership with global manufacturing leader IMA Group.
Connectivity Key to Industry 4.0 October 9, 2020 Most machining operations today have a heterogenous mix of old and new machines. To achieve a future Smart Factory means connecting existing machining centers, and GROB offers solutions.
In the thick of the ‘herculean’ vaccine push September 21, 2020 In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.